Evidence tells you if it is effective or not but doesn’t tell you if it is worth it. Health economic studies for pharmaceuticals, biologics, diagnostics, biomarkers and medical devices combine measuring both outcomes and costs to judge the value of innovative interventions. These studies include; budget impact, cost utility, cost-effectiveness, cost minimization, cost benefit analyses, and cost of illness.
x
- [email protected]
- Cairo , Egypt
Research
Research for The Professionals
Scientific Research Publishing
Global Journal on Quality and Safety in Healthcare (JQSH) (jqsh.org) is a peer-reviewed, open-access journal that is published quarterly by the Innovative Healthcare Institute (Cincinnati, OH, USA) (innovativehci.com). JQSH aims to help healthcare professionals improve their practice by publishing evidence from real-world examples of quality and safety improvement outcomes in various disciplines, environments, and countries. Our readership includes physicians, nurses, pharmacists, quality improvement staff, healthcare administrators, allied health professionals, and others.
The scope of the Journal includes topics related to healthcare delivery across multiple disciplines including all domains of quality improvement, such as safety, effectiveness, efficiency, timeliness, equity, and patient-centered care. Manuscripts related to cost effectiveness, health economics, health policy, and public health issues will be considered. The Journal publishes original research, quality improvement projects, systematic and narrative reviews of the literature, case studies, and more.
To learn more and submit a manuscript, visit jqsh.org.
